Each month in eINFO, Hypertension Canada provides a summary of members' publications from PubMed. Check out the May 2013 publications list.

  

With the increasing interest in renal denervation, this month we would like to draw your attention to the following article: Effectiveness of Renal Denervation Therapy for Resistant Hypertension: A Systematic Review and Meta-Analysis.   Davis MI, Filion KB, Zhang D, Eisenberg MJ, Afilalo J, Schiffrin EL, Joyal D.

Source - Division of Internal Medicine, Jewish General Hospital, McGill University, Montreal, Canada.  

IN FOCUS                     

  

From October 17-20th, 2013, the Canadian Hypertension Congress will join forces with the Canadian Stroke Congress, the Canadian Diabetes Association/Canadian Society of Endocrinology and Metabolism Professional Conference and the Canadian Cardiovascular Congress for Vascular 2013 at the Palais des Congrès de Montréal.

 

Vascular 2013, a one-time Canadian event, will bring Canada's key medical conferences under one roof and mark an unprecedented educational and community building opportunity. Physicians, scientists, clinicians, nurses, educators, allied health professionals, and policy makers will be there.

 

By registering to the CHC you will have access to all other host organizations' programs. On Friday, October 18th, the joint Vascular Day will focus on vascular science.

Preliminary Program

 

Be sure to attend this unique one-time Vascular Day event, featuring a presentation on "How To Change Habits at a Population Level" by world-renowned Prof. Jaako Tuomilehto MD, PhD from the University of Helsinki, Finland. Vascular Day is also offering an extensive variety of concurrent sessions, including the Prevention of Vascular Disease and Promotion of Healthy Populations, Interdisciplinary Management of the Complex Patient and Basic Biomedical Aspects of Vascular Health from top Canadian leaders in Vascular Health.

 

Here are a few CHC 2013 program highlights:

• Core Curriculum presented in association with the Heart & Stroke Foundation and the Canadian Stroke Network will bring together thought leaders on topics ranging from Promoting Healthy Behaviours for Primary Prevention of Atherosclerosis, Global Risk Assessment for Primary Prevention of Atherosclerosis, BP Thresholds and Targets - What, for Whom, and Why? and The Evidence Behind CHEP's Firstline Recommendations for the Treatment of Hypertension
• Symposia in collaboration with Canadian Cardiovascular Society and Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology
• CHEP Symposium focusing on the 2014 draft CHEP recommendations
• PLUS workshops, poster sessions and state-of-the-art lectures from leading Canadian cardiovascular scientists! 

For complete details visit 

http://www.hypertension.ca/chc-scientific-program